Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Suzanne Armstrong | F | - | 17 years | |
| Roberto Donadello | M | - | 17 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert S. Vaters | M | 63 | 5 years | |
| Brian McCollum | M | 48 | 12 years | |
| Christian Itin | M | 59 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 6 years |
| Mark S. Deutsch | M | 61 | 14 years | |
| Arthur Levine | M | 66 | 2 years | |
| Alan Milinazzo | M | 64 | 7 years | |
| Jeffrey Michael Schumm | M | 62 | 9 years | |
| Matthias Alder | M | 59 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 6 years |
| Guy J. Jordan | M | 75 | 13 years | |
| Michael R. Mainelli | M | 62 | 4 years | |
| David M. Templeton | M | 70 | - | |
| Tim Adams | M | 64 | 1 years | |
| Dan Yarbrough | M | - | - | |
| Peter Johann | M | 67 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | - |
| James Gero | M | 79 | 15 years | |
| Walter P. von Wartburg | M | 84 | 10 years | |
| Raymond C. Kolls | M | 61 | 6 years | |
| Kenneth R. Weisshaar | M | 73 | 10 years | |
| Joseph Slattery | M | 59 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 5 years |
| Eric Brown | M | 54 | 21 years | |
| Philippe Gadal | M | 66 | 6 years | |
| Kapil Dhingra | M | 64 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 3 years |
| Ashley Hall | F | 52 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 2 years |
| Andrea Mercanti | M | - | 1 years | |
| Patrice R. Debrégeas | M | 80 | 2 years | |
| Otello Stampacchia | M | 55 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 4 years |
| Oliver Burckhardt | M | - | 2 years | |
| Kishore Dudani | M | 68 | 7 years | |
| Michael P. Simpson | M | 62 | 9 years | |
| Michael Finegan | M | 60 | 14 years | |
| Kevin Unger | M | 52 | 2 years | |
| Mark Reisenauer | M | 58 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 4 years |
| Donald A. Zelm | M | 68 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 2 years |
| Laurent Le Portz | M | 58 | 2 years | |
| Donald Morton | M | - |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | - |
| Emily V. Buxton | F | 47 | 11 years | |
| Trent Wood | M | - | - | |
| Bryan McMillan | M | 54 | 2 years | |
| Denise Pedulla | F | 64 | 3 years | |
| Rhonda L. Fellows | F | 68 | 9 years | |
| William LaRue | M | 73 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 5 years |
| Duane M. Steele | M | 73 | 13 years | |
| Christopher P. Schnittker | M | 55 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 1 years |
| Robert E. Kiss | M | - |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | - |
| Glenn Halpryn | M | 63 | 6 years | |
| James Clayburn la Force | M | 95 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | - |
| Alberto C. d'Abreu de Paulo | M | 85 | 13 years | |
| Charles Federico | M | 75 | 14 years | |
| Frederik Hartsuiker | M | - | - | |
| Thomas M. Hein | M | 76 | - | |
| Gary D. Henley | M | 75 | 9 years | |
| Peter J. Hewett | M | 88 | 17 years | |
| Jose J. Valdes-Fauli | M | 72 | 6 years | |
| Maria Degois Sainz | F | 58 | 3 years | |
| Guy M. Gammon | M | - |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | - |
| Luigi Ferrari | M | 56 | - | |
| Robert Gaines-Cooper | M | 87 | - | |
| Paul F. Kennedy | M | 79 | 3 years | |
| Charles R. Struby | M | 74 | 1 years | |
| Jan C. Fagerberg | M | 62 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | - |
| Steven E. Lufkin | M | 61 | - | |
| Thomas Kester | M | 77 | 6 years | |
| Fernando Fernandez | M | 63 | 3 years | |
| Phillip Schneider | M | 68 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 1 years |
| Lawrence G. Meyer | M | 83 | 2 years | |
| Ivor Royston | M | 79 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | - |
| Gail S. Schoettler | M | 80 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | - |
| Stefan K. Widensohler | M | 64 | - | |
| Carsten Reinhardt | M | 57 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 71 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jerry Christopher Benjamin
- Personal Network
